What Researchers Did
Researchers combined data from 19 studies using a statistical method called network meta-analysis to compare 12 different treatments for medication-related osteonecrosis of the jaw, a bone condition linked to certain drugs.
What They Found
This systematic review and Bayesian network meta-analysis of 1,064 patients with medication-related osteonecrosis of the jaw found that the treatments studied improved healing rates compared to conventional surgery alone (RR 1.44, 95% CI 1.20 to 1.71, p less than 0.001) and reduced new cases in high-risk patients (RR 0.10, 95% CI 0.04 to 0.29, p less than 0.001). When treatments were ranked by a probability-weighted score called SUCRA, BMP-2 combined with L-PRF scored highest for healing (89.3%), hyperbaric oxygen scored second (84.1%), and YAG laser combined with low-level laser therapy scored third (67.8%). These SUCRA scores reflect a statistical ranking across the network of studies, not a measured cure or success rate for any single treatment.
What This Means for Canadian Patients
For Canadian patients with medication-related osteonecrosis of the jaw, this analysis suggests that combining active treatments with surgery may lead to better healing than surgery alone, and that hyperbaric oxygen was one of the higher-ranked options in this indirect statistical comparison. The abstract does not report that hyperbaric oxygen was tested head-to-head against surgery or against the other therapies, so patients should discuss with their care team which specific approach fits their case.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Because this is a network meta-analysis, the treatment rankings come from indirect statistical comparisons across different trials rather than direct head-to-head testing, which limits how confidently any single treatment, including hyperbaric oxygen, can be called better than another.